Search hospitals > Louisiana > Monroe
Delta Research Partners
Claim this profileMonroe, Louisiana 71201
Global Leader in Inflammatory Bowel Disease
Global Leader in Ulcerative Colitis
Conducts research for Ulcer
Conducts research for Colorectal Cancer
Conducts research for Fatty Liver Disease
51 reported clinical trials
4 medical researchers
Summary
Delta Research Partners is a medical facility located in Monroe, Louisiana. This center is recognized for care of Inflammatory Bowel Disease, Ulcerative Colitis, Ulcer, Colorectal Cancer, Fatty Liver Disease and other specialties. Delta Research Partners is involved with conducting 51 clinical trials across 42 conditions. There are 4 research doctors associated with this hospital, such as Bal Raj Bhandari, Henry Hill Hinkle, III, Henry Hinkle III, MD, and Henry Hill Hinkle III.Top PIs
Bal Raj BhandariDelta Research Partners4 years of reported clinical research
Studies Crohn's Disease
Studies Ulcer
4 reported clinical trials
4 drugs studied
Henry Hill Hinkle, IIIDelta Research Partners LLC5 years of reported clinical research
Studies Crohn's Disease
Studies Inflammatory Bowel Disease
3 reported clinical trials
3 drugs studied
Henry Hinkle III, MDDelta Research Partners1 year of reported clinical research
Studies Ulcerative Colitis
Studies Inflammatory Bowel Disease
1 reported clinical trial
2 drugs studied
Henry Hill Hinkle IIIDelta Research Partners6 years of reported clinical research
Studies Inflammatory Bowel Disease
Studies Ulcer
2 reported clinical trials
1 drug studied
Clinical Trials running at Delta Research Partners
Ulcerative Colitis
Crohn's Disease
Ulcer
Inflammatory Bowel Disease
Gastroparesis
Type 2 Diabetes
Mirikizumab
for Ulcerative Colitis
This trial is testing mirikizumab, a medication for people with severe ulcerative colitis. It aims to see if the drug can reduce gut inflammation by blocking a protein that causes it. The study will last several years. Mirikizumab has shown positive results in early tests for ulcerative colitis.
Recruiting2 awards Phase 31 criteria
PL-8177
for Ulcerative Colitis
The purpose of this study is to compare PL8177 (a melanocortin receptor agonist) to placebo (in a 3:1 ratio-meaning that for every 3 people that get the active drug, one will receive placebo). The study treatment will be for 8 weeks. The study will measure safety and the body's ability to handle PL8177 and look at the improvement and healing of the intestine after 8 weeks of treatment. The study will include adult males and nonpregnant, nonlactating females with acute Ulcerative Colitis (UC).
Recruiting0 awards Phase 27 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Delta Research Partners?
Delta Research Partners is a medical facility located in Monroe, Louisiana. This center is recognized for care of Inflammatory Bowel Disease, Ulcerative Colitis, Ulcer, Colorectal Cancer, Fatty Liver Disease and other specialties. Delta Research Partners is involved with conducting 51 clinical trials across 42 conditions. There are 4 research doctors associated with this hospital, such as Bal Raj Bhandari, Henry Hill Hinkle, III, Henry Hinkle III, MD, and Henry Hill Hinkle III.